IMU Biosciences

IMU BiosciencesIMU Biosciences
IMU Biosciences

IMU Biosciences

Decoding the immune system to pioneer a paradigm shift in disease diagnosis and treatment.

Website
DR 24ActiveLondon, United Kingdom
Rate
Advertise here

About

IMU Biosciences is a biotechnology company developing "HD Immunology" by decoding the immune system with unprecedented resolution and scale. Their core offering is a multi-omic platform that generates over 100 million immune data points from 2ml of blood, resolving 2,500 discrete immune cell subsets in real-time to build the world's largest immune dataset. This platform powers precision medicine initiatives, including predictive screening tools for Hematopoietic Stem Cell Transplantation and graft rejection in Solid Organ Transplantation.
Frequently asked

What does IMU Biosciences do?

IMU Biosciences is a biotechnology company developing "HD Immunology" by decoding the immune system with unprecedented resolution and scale. Their core offering is a multi-omic platform that generates over 100 million immune data points from 2ml of blood, resolving 2,500 discrete immune cell subsets in real-time to build the world's largest immune dataset. This platform powers precision medicine initiatives, including predictive screening tools for Hematopoietic Stem Cell Transplantation and gra…

What is IMU Biosciences's revenue?

StartupHub estimates IMU Biosciences's annual revenue at $5.7M (range $1.7M to $20.8M, 35% confidence), based on comparable companies in the sector.

What is IMU Biosciences's valuation?

StartupHub estimates IMU Biosciences's effective valuation at $224.7M (range $132.5M to $318.0M, 24% confidence), based on comparable companies in the sector.

How much funding has IMU Biosciences raised?

IMU Biosciences has raised a total of $53M in funding. The most recent round on record is Series A.

Where is IMU Biosciences headquartered?

IMU Biosciences is headquartered in London, England, United Kingdom.

What industry does IMU Biosciences operate in?

IMU Biosciences operates in Biotechnology, Artificial Intelligence, HealthTech, Drug Discovery, Biotech, Genomics.

Comments

No comments yet. Be the first to share your take.